U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H31N3O3.2ClH
Molecular Weight 458.422
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BMY-7378

SMILES

Cl.Cl.COC1=CC=CC=C1N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2

InChI

InChIKey=NIBOMXUDFLRHRV-UHFFFAOYSA-N
InChI=1S/C22H31N3O3.2ClH/c1-28-19-7-3-2-6-18(19)24-13-10-23(11-14-24)12-15-25-20(26)16-22(17-21(25)27)8-4-5-9-22;;/h2-3,6-7H,4-5,8-17H2,1H3;2*1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C22H31N3O3
Molecular Weight 385.4998
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/1970304

BMY-7378 is a multi-targeted inhibitor of α2C-adrenoceptor and α1D-adrenoceptor with pKi of 6.54 and 8.2, respectively, and acts as a mixed agonist and antagonist for 5-HT1A receptor with pKi of 8.3. BMY-7378 was at the preclinical stage of development for the treatment of anxiety disorders, but later was discontinued.

CNS Activity

Originator

Curator's Comment: # Bristol-Myers Squibb

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Mechanical function and gene expression of alpha(1)-adrenoceptor subtypes in dog intravesical ureter.
2009-08
Adventitia removal does not modify the alphaID-adrenoceptors response in aorta during hypertension and ageing.
2009-07
Inhibitory effect of fentanyl on phenylephrine-induced contraction of the rat aorta.
2009-06-30
Phenylephrine contracts porcine pulmonary veins via alpha(1B)-, alpha(1D)-, and alpha(2)-adrenoceptors.
2009-06-24
The alpha1D-adrenergic receptor induces vascular smooth muscle apoptosis via a p53-dependent mechanism.
2008-10
Smooth muscle alpha1D-adrenoceptors mediate phenylephrine-induced vasoconstriction and increases in endothelial cell Ca2+ in hamster cremaster arterioles.
2008-10
Different affinities of native alpha1B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations.
2008-04-28
Noradrenergic vasoconstriction of pig prostatic small arteries.
2008-02
alpha1-Adrenoceptors in proximal segments of tail arteries from control and reserpinised rats.
2007-10
Alpha1A-adrenoceptors predominate in the control of blood pressure in mouse mesenteric vascular bed.
2007-07
Identification of alpha-1L and alpha-1A adrenoceptors in human prostate by tissue segment binding.
2007-01
Effects of alpha1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells.
2006-11
Selective agonists reveal alpha(1A)- and alpha(1B)-adrenoceptor subtypes in caudal artery of the young rat.
2006-10
Alpha(1A/L)-adrenoceptors mediate contraction of the circular smooth muscle of the pig urethra.
2006-10
Sympathetic neurotransmission in the rat testicular capsule: functional characterization and identification of mRNA encoding alpha1-adrenoceptor subtypes.
2006-08-14
Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional entity.
2006-01
Correlation between mRNA levels and functional role of alpha1-adrenoceptor subtypes in arteries: evidence of alpha1L as a functional isoform of the alpha1A-adrenoceptor.
2005-11
Differential distribution of functional alph}1-adrenergic receptor subtypes along the rat tail artery.
2005-08
Pharmacological characterization of alpha1-adrenoceptors in mouse isolated femoral small arteries.
2004-10-25
Cloned human 5-HT1A receptor pharmacology determined using agonist binding and measurement of cAMP accumulation.
2004-10
Chromatography studies on bio-affinity of nine ligands of alpha1-adrenoceptor to alpha1D subtypes overexpressed in cell membrane.
2004-08
The hypotensive effect of BMY 7378 involves central 5-HT1A receptor stimulation in the adult but not in the young rat.
2004-04-02
Evidence that alpha(1B)-adrenoceptors are involved in noradrenaline-induced contractions of rat tail artery.
2004-03-19
Alpha 1-adrenoceptor subtypes mediating noradrenaline-induced contraction of pulmonary artery from pulmonary hypertensive rats.
2003-12-15
Effects of castration and of testosterone replacement on alpha(1)-adrenoceptor subtypes in the rat vas deferens.
2003-06-20
Functional characterization of alpha-adrenoceptors mediating pupillary dilation in rats.
2003-06-20
Cytosolic Ca2+ and phosphoinositide hydrolysis linked to constitutively active alpha 1D-adrenoceptors in vascular smooth muscle.
2003-06
Interaction between neuropeptide Y Y1 receptors and alpha1B-adrenoceptors in the neurovascular junction of canine splenic arteries.
2003-04-18
Evidence for the role of alpha1D- and alpha1A-adrenoceptors in contraction of the rat mesenteric artery.
2003-02
Serotonergic serotonin (1A) mixed agonists/antagonists elicit large-magnitude phase shifts in hamster circadian wheel-running rhythms.
2003
Pharmacological characterization of alpha1-adrenoceptor in mouse iliac artery.
2002-12-05
5-HT1A receptor-mediated regulation of mitogen-activated protein kinase phosphorylation in rat brain.
2002-10-04
alpha(1A)-adrenoceptors mediate sympathetically evoked pupillary dilation in rats.
2002-02
Functional characterization of alpha1-adrenoceptor subtypes in human subcutaneous resistance arteries.
2001-11
The hypotensive effect of BMY 7378 is antagonized by a silent 5-HT(1A) receptor antagonist: comparison with 8-hydroxy-dipropylamino tetralin.
2001-10-02
Molecular cloning and functional expression of the guinea pig alpha(1a)-adrenoceptor.
2001-08-31
Characterization of alpha1-adrenoceptor-mediated contraction in the mouse thoracic aorta.
2001-07-20
Alpha1-adrenoceptor subtypes on rat afferent arterioles assessed by radioligand binding and RT-PCR.
2001-07
Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes.
2001-06
Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.
2001-05-07
Use of antisense oligonucleotides to verify the role of the alpha(1A)-adrenergic receptor in the contractility of the rat uterus post partum.
2001-05
Failure of AH11110A to functionally discriminate between alpha(1)-adrenoceptor subtypes A, B and D or between alpha(1)- and alpha(2)-adrenoceptors.
2001-03
Characterization of alpha1-adrenoceptor subtypes mediating noradrenaline-induced contraction of rat epididymal vas deferens in calcium-free medium.
1999
Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
1997
Patents

Sample Use Guides

Rats: BMY-7378 dose dependently (0.25-5 mg/kg s.c.) reduces the undetectable levels forepaw treading and head weaving induced by 8-OH-DPAT (0.75 mg/kg s.c.) in rats.
Route of Administration: Other
In Vitro Use Guide
BMY-7378 at concentration of 1 nM to 30 nM elicits inhibitory effects in a concentration-dependent manner in the rat dorsal raphe nucleus.
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:55:57 GMT 2025
Edited
by admin
on Mon Mar 31 22:55:57 GMT 2025
Record UNII
KC07KV8T5O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1,1-CYCLOPENTANEDIACETIMIDE, N-(2-(4-(O-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-, DIHYDROCHLORIDE
Preferred Name English
BMY-7378
Common Name English
8-AZASPIRO(4.5)DECANE-7,9-DIONE, 8-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-, DIHYDROCHLORIDE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID10175334
Created by admin on Mon Mar 31 22:55:57 GMT 2025 , Edited by admin on Mon Mar 31 22:55:57 GMT 2025
PRIMARY
PUBCHEM
210172
Created by admin on Mon Mar 31 22:55:57 GMT 2025 , Edited by admin on Mon Mar 31 22:55:57 GMT 2025
PRIMARY
CAS
21102-95-4
Created by admin on Mon Mar 31 22:55:57 GMT 2025 , Edited by admin on Mon Mar 31 22:55:57 GMT 2025
PRIMARY
WIKIPEDIA
BMY-7378
Created by admin on Mon Mar 31 22:55:57 GMT 2025 , Edited by admin on Mon Mar 31 22:55:57 GMT 2025
PRIMARY
FDA UNII
KC07KV8T5O
Created by admin on Mon Mar 31 22:55:57 GMT 2025 , Edited by admin on Mon Mar 31 22:55:57 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Binding assay
IC50
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY